Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 143.26
0.944 %
$ 14.5 B
Market Cap
38.2
P/E
Price Target
Average
12.80%
Revenue Forecast
Estimate
30.20%
EBIT
Estimate
54.93%
Net Income
Estimate
77.28%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Neurocrine Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for NBIX of $162 , with forecasts ranging from
a
low of
$121 to a high of $200 .
NBIX Lowest Price Target
Wall Street Target
121 USD
-15.54%
NBIX Average Price Target
Wall Street Target
162 USD
12.80%
NBIX Highest Price Target
Wall Street Target
200 USD
39.61%
REVENUE FORECAST
Revenue Forecast Chart NBIX
EBIT FORECAST
EBIT Forecast Chart NBIX
NET INCOME FORECAST
Net Income Chart NBIX